The FEI introduced an objective tool for measuring the tightness of nosebands at all FEI events across all disciplines. It is set to roll out during the first quarter of 2025.
In collaboration with external experts, the International Equestrian governing body (FEI) developed a device for measuring the tightness of nosebands. It will be used at all FEI events across all disciplines, and is set to gradually roll out during the first quarter of 2025. The "FEI Measuring Device" is positioned beneath the noseband, across the nasal bone, and is pulled through from top to bottom, serving as a pass-through tool. Per Article 1044.8 of the FEI Veterinary Regulations, if the device is unable to easily pass through a noseband (upper and lower), the noseband is deemed to be excessively tightened, and if discovered —
Pre-Competition: The horse and athlete combination is not allowed to start unless the noseband is re-adjusted to allow enough laxity.
During the competition, the horse and athlete combination is eliminated from the competition in question, and the athlete is issued with a yellow warning card.
Equestrian sports' international governing body unveils its mission, "to lead, drive, and develop the highest standards of equine sport globally." FEI Secretary General Sabrina Ibáñez sets forth the plan in this YouTube video, urging everyone to act as guardians to ensure a "good life for horses." Learn more about the horse welfare plan at https://www.fei.org/stories/lifestyle/horse-human/guardians.
Flyinge hosted the Horse Welfare Summit, Northern Europe's largest event dedicated to horse welfare. The summit spanned two full days and featured lectures, clinics, and panel discussions led by prominent experts in the field.
"From the Air you breathe, to the ground beneath your feet, you deserve the very BEST. Your well-being is our inspiration."
Scholarship recipient Eva Skiöldebrand was part of a research team conducting a clinical study of a novel drug combination that was effective in treating osteoarthritis-associated lameness in horses and restoring joint tissue. The findings could have implications for treating ostearthritis in humans as well, since horses and humans are genetically very similar. The researchers hope to conduct a clinical trial of the drug treatment in humans next.